Dergiler / Diagnostic and Interventional Radiology / 2021 / Cilt: 27 - Sayı: 3

Prognostic value of mediastinal lymph node enlargement in chronic interstitial lung disease

Sayfa
329–335
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Patients with MLN enlargement experienced greater number of hospitalizations for respiratory causes (mean 2.5 vs. 1.8, p = 0.010) and had significantly worse lung function parameters (FVC, 71% vs. 81%, p = 0.018 and DLCO, 40% vs. 50%, p = 0.001) and a higher lung fibrosis score (50% vs. 39%, p = 0.001).CONCLUSIONIn patients with IPF and NSIP, enlarged MLNs predict survival, are associated with increased number of hospitalizations, and show signs of poorer lung function and more severe fibrosis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:PURPOSE Mediastinal lymph node (MLN) enlargement detected on chest computed tomography (CT) is frequent in patients with interstitial lung disease (ILD) and is shown in approximately 70% of cases of idiopathic pulmonary fibrosis (IPF).
📊
Temel Bulgular & Veri:We hypothesized that enlarged MLNs might be a predictor of poor prognosis, associated with lower survival and stronger disease severity.METHODSThis study included patients with idiopathic pulmonary fibrosis (IPF) or nonspecific interstitial pneumonia (NSIP) from January 2009 to December 2018.
💡
Sonuç & Katkı:Patients with MLN enlargement experienced greater number of hospitalizations for respiratory causes (mean 2.5 vs. 1.8, p = 0.010) and had significantly worse lung function parameters (FVC, 71% vs. 81%, p = 0.018 and DLCO, 40% vs. 50%, p = 0.001) and a higher lung fibrosis score (50% vs. 39%, p = 0.001).CONCLUSIONIn patients with IPF and NSIP, enlarged MLNs predict survival, are associated with increased number of hospitalizations, and show signs of poorer lung function and more severe fibrosis.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2009 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

PURPOSE Mediastinal lymph node (MLN) enlargement detected on chest computed tomography (CT) is frequent in patients with interstitial lung disease (ILD) and is shown in approximately 70% of cases of idiopathic pulmonary fibrosis (IPF). We hypothesized that enlarged MLNs might be a predictor of poor prognosis, associated with lower survival and stronger disease severity.METHODSThis study included patients with idiopathic pulmonary fibrosis (IPF) or nonspecific interstitial pneumonia (NSIP) from January 2009 to December 2018. Baseline chest CT scan and one-year follow-up scan of the patients were reviewed for the extent of lung fibrosis and MLNs. Two radiologists independently assessed MLN diameter and location. Patients with drug toxicity-related ILD, sarcoidosis, chronic hypersensitivity pneumonitis and other rare idiopathic interstitial pneumonias were excluded. The primary endpoint was survival. Secondary endpoints included number of hospitalizations for respiratory causes, lung function evaluated by forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLCO), and lung fibrosis score determined by CT scan. RESULTSWe retrospectively reviewed the medical registries of 110 patients with chronic pulmonary fibrosis (mean age 71 years, 60.4% male). Nine participants were excluded because the CT scans were of poor diagnostic quality for the evaluation of the mediastinum or unavailable for review. The analysis of 101 patients showed that enlarged MLNs (short axis diameter ≥10 mm) were present in 50.5% (n=51) and strongly predicted survival (HR= 2.11, 95% CI 1.12–3.96, p = 0.020). Patients with MLN enlargement experienced greater number of hospitalizations for respiratory causes (mean 2.5 vs. 1.8, p = 0.010) and had significantly worse lung function parameters (FVC, 71% vs. 81%, p = 0.018 and DLCO, 40% vs. 50%, p = 0.001) and a higher lung fibrosis score (50% vs. 39%, p = 0.001).CONCLUSIONIn patients with IPF and NSIP, enlarged MLNs predict survival, are associated with increased number of hospitalizations, and show signs of poorer lung function and more severe fibrosis.

🔖

Bu Makaleye Atıf Yap

GRECUCCIO, S., SVERZELATTİ, N., USLENGHI, E., CAMINATI, A., PEDRAZZI, G., ZOMPATORI, M. (2021). Prognostic value of mediastinal lymph node enlargement in chronic interstitial lung disease. Diagnostic and Interventional Radiology, Cilt: 27 - Sayı: 3, 329–335. https://ajindex.com/articles/349967

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Ley B, Elicker BM, Hartman TE, et al. Idiopathic pulmonary fibrosis: CT and risk of death. Radiology 2014
  2. 570–579. [Crossref] 2. Nakagawa H, Fukunaga K, Ikeda S, et al. Prognostic factors in patients with idiopathic pulmonary fibrosis
  3. evaluation using quantitative CT analysis of fibrosis and emphysema. Eur Respir J 2019
  4. 54(Suppl 63): Abstract 1332. [Crossref] 3. Jacob J, Bartholmai B, Rajagopalan S, et al. Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures. Eur Respir J 2017
  5. 1601011. [Crossref] 4. Watadani T, Sakai F, Johkoh T, et al. Interobserver variability in the CT assessment of honeycombing in the lungs. Radiology 2013
  6. 936–944. [Crossref] 5. Adegunsoye A, Oldham JM, Bonham C, et al. Prognosticating outcomes in interstitial lung disease by mediastinal lymph node assessment. an observational cohort study with independent validation. Am J Resp Crit Care Med 2019
  7. 747–759. [Crossref] 6. Ryerson CJ, Vittinghoff E, Ley B, et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest 2014
  8. 723–728. [Crossref] 7. Udoji TN, Phillips GS, Berkowitz EA, Berkowitz D, Ross C, Bechara RI. Mediastinal and hilar lymph node measurements. comparison of multidetector-row computed tomography and endobronchial ultrasound. Ann Am Thorac Soc 2015
  9. 914–920. [Crossref] 8. Walker CM, Chung JH, Abbott GF, et al. Mediastinal lymph node staging: from noninvasive to surgical. AJR Am J Roentgenol 2012
  10. W54– 64. [Crossref] 9. Glazer GM, Gross BH, Quint LE, Francis IR, Bookstein FL, Orringer MB. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. AJR Am J Roentgenol 1985
  11. 261–265. [Crossref] 10. Jacob J, Bartholmai BJ, Rajagopalan S, et al. Automated quantitative computed tomography versus visual computed tomography scoring in idiopathic pulmonary fibrosis: validation against pulmonary function. J Thorac Imaging 2016
  12. 304–311. [Crossref] 11. Sánchez RP, Fabrellas EF, Samper GJ, Montañana MLD, Vilar LN. Visual HRCT score to determine severity and prognosis of idiopathic pulmonary fibrosis. Int J Respir Pulm Med 2018
  13. [Crossref] 12. Sverzellati N, Calabrò E, Chetta A, et al. Visual score and quantitative CT indices in pulmonary fibrosis: Relationship with physiologic impairment. Radiol Med 2007
  14. 1160–1172. [Crossref] 13. Best AC, Lynch AM, Bozic CM, Miller D, Grunwald GK, Lynch DA